ICAM-1 (Lys469Glu) and PECAM-1 (Leu125Val) polymorphisms in diffuse astrocytomas

被引:21
作者
Burim, Regislaine Valeria [1 ,2 ]
Teixeira, Silvia Aparecida [2 ]
Colli, Benedicto Oscar [2 ]
Peria, Fernanda Maris [3 ]
Tirapelli, Luis Fernando [2 ]
Nagahashi Marie, Suely Kazue [4 ]
Fleury Malheiros, Suzana Maria [5 ]
Oba-Shinjo, Sueli Mieko [6 ]
Gabbai, Alberto Alain [5 ]
Lotufo, Paulo Andrade [7 ]
Carlotti-Junior, Carlos Gilberto [2 ]
机构
[1] Univ Sao Paulo, FCFRP, Sch Pharmaceut Sci Ribeirao Preto, Dept Clin Toxicol & Bromatol Anal, BR-14040903 Ribeirao Preto, SP, Brazil
[2] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Surg & Anat, BR-14040903 Ribeirao Preto, SP, Brazil
[3] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Internal Med, BR-14040903 Ribeirao Preto, SP, Brazil
[4] Univ Sao Paulo, Fac Med, Dept Neurol, Sao Paulo, Brazil
[5] Univ Fed Sao Paulo, Fac Med, Dept Neurol, Sao Paulo, Brazil
[6] Univ Sao Paulo, Fac Med, Dept Internal Med, Sao Paulo, Brazil
[7] Univ Sao Paulo, Sao Paulo Univ Hosp, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
Astrocytoma; Polymorphism; PECAM-1; ICAM-1; INTERCELLULAR-ADHESION MOLECULE-1; ACUTE MYOCARDIAL-INFARCTION; INFLAMMATORY-BOWEL-DISEASE; VERSUS-HOST-DISEASE; GENE POLYMORPHISMS; MULTIPLE-SCLEROSIS; JAPANESE POPULATION; BEHCETS-DISEASE; CELL MIGRATION; SOLUBLE LEVEL;
D O I
10.1007/s10238-009-0040-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Cell adhesion molecules such as intercellular adhesion molecule-1 (ICAM-1) and platelet-endothelial cell adhesion molecule-1 (PECAM-1) play an important role in glioma invasion and angiogenesis. The aim of this study was to investigate whether specific genetic polymorphisms of ICAM-1 and PECAM-1 could be associated with glioma development and progression. Single-nucleotide polymorphism in codon 469 of ICAM-1 and codon 125 of PECAM-1 were examined in 158 patients with astrocytomas and 162 controls using polymerase chain reaction and restriction enzyme analysis. The distribution of PECAM-1 polymorphic genotypes in astrocytomas did not show any significant difference. However, a specific ICAM-1 genotype (G/G, corresponding to Lys469Glu) exhibited higher frequency in grade II astrocytomas compared to controls, grade III, and grade IV astrocytomas; suggesting that this polymorphism could be involved in the development of grade II astrocytomas.
引用
收藏
页码:157 / 163
页数:7
相关论文
共 59 条
[1]   EXPRESSION OF INTERCELLULAR-ADHESION MOLECULE (ICAM)-1 BY A SUBSET OF ASTROCYTES IN ALZHEIMER-DISEASE AND SOME OTHER DEGENERATIVE NEUROLOGICAL DISORDERS [J].
AKIYAMA, H ;
KAWAMATA, T ;
YAMADA, T ;
TOOYAMA, I ;
ISHII, T ;
MCGEER, PL .
ACTA NEUROPATHOLOGICA, 1993, 85 (06) :628-634
[2]   The cellular immunology of multiple sclerosis [J].
Al-Omaishi, J ;
Bashir, R ;
Gendelman, HE .
JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 65 (04) :444-452
[3]   ENDOCAM - A NOVEL ENDOTHELIAL-CELL CELL-ADHESION MOLECULE [J].
ALBELDA, SM ;
OLIVER, PD ;
ROMER, LH ;
BUCK, CA .
JOURNAL OF CELL BIOLOGY, 1990, 110 (04) :1227-1237
[4]  
Amoli MM, 2001, J RHEUMATOL, V28, P1014
[5]   Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies [J].
Andreotti, F ;
Porto, I ;
Crea, F ;
Maseri, A .
HEART, 2002, 87 (02) :107-112
[6]   Expression of PECAM-1/CD31 isoforms in human brain gliomas [J].
Aroca, F ;
Renaud, W ;
Bartoli, C ;
Bouvier-Labit, C ;
Figarella-Branger, D .
JOURNAL OF NEURO-ONCOLOGY, 1999, 43 (01) :19-25
[7]  
Auer Johann, 2003, Am J Pharmacogenomics, V3, P317, DOI 10.2165/00129785-200303050-00003
[8]  
Behar E, 1996, NEW ENGL J MED, V334, P286, DOI 10.1056/NEJM199602013340502
[9]   Polymorphisms of the ICAM-1 gene are associated with inflammatory bowel disease, regardless of the p-ANCA status [J].
Braun, C ;
Zahn, R ;
Martin, K ;
Albert, E ;
Folwaczny, C .
CLINICAL IMMUNOLOGY, 2001, 101 (03) :357-360
[10]   COEXPRESSION OF B7-1 AND ICAM-1 ON TUMORS IS REQUIRED FOR REJECTION AND THE ESTABLISHMENT OF A MEMORY RESPONSE [J].
CAVALLO, F ;
MARTINFONTECHA, A ;
BELLONE, M ;
HELTAI, S ;
GATTI, E ;
TORNAGHI, P ;
FRESCHI, M ;
FORNI, G ;
DELLABONA, P ;
CASORATI, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (05) :1154-1162